150 related articles for article (PubMed ID: 25346892)
1. Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type.
Sureshkumar KK; Hussain SM; Thai NL; Ko TY; Nashar K; Marcus RJ
World J Transplant; 2014 Sep; 4(3):188-95. PubMed ID: 25346892
[TBL] [Abstract][Full Text] [Related]
2. Influence of maintenance steroids on the outcomes in deceased-donor kidney transplant recipients exposed to prolonged pretransplantation dialysis.
Sureshkumar KK; Hussain SM; Thai NL; Marcus RJ
Transplant Proc; 2013; 45(1):99-101. PubMed ID: 23375281
[TBL] [Abstract][Full Text] [Related]
3. Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.
Sureshkumar KK; Hussain SM; Nashar K; Marcus RJ
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):741-9. PubMed ID: 24969182
[TBL] [Abstract][Full Text] [Related]
4. Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
Sureshkumar KK; Thai NL; Hussain SM; Ko TY; Marcus RJ
Transplantation; 2012 Apr; 93(8):799-805. PubMed ID: 22290269
[TBL] [Abstract][Full Text] [Related]
5. Influence of steroid maintenance on the outcomes in deceased donor kidney transplant recipients experiencing delayed graft function.
Tangirala B; Marcus RJ; Hussain SM; Sureshkumar KK
Indian J Nephrol; 2013 Nov; 23(6):403-8. PubMed ID: 24339515
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK
Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720
[TBL] [Abstract][Full Text] [Related]
7. Role of steroid maintenance in sensitized kidney transplant recipients.
Sureshkumar KK; Marcus RJ; Chopra B
World J Transplant; 2015 Sep; 5(3):102-9. PubMed ID: 26421263
[TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab induction in deceased donor kidney transplantation.
Huang E; Cho YW; Hayashi R; Bunnapradist S
Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833
[TBL] [Abstract][Full Text] [Related]
9. Primary pediatric deceased-donor kidney transplant recipients outcomes by immunosuppression induction received in the United States.
Riad S; Jackson S; Chinnakotla S; Verghese P
Pediatr Transplant; 2021 Aug; 25(5):e13928. PubMed ID: 33314638
[TBL] [Abstract][Full Text] [Related]
10. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
11. Effect of induction agent on posttransplant outcomes in deceased donor kidney transplant recipients: influence of race.
Hussain SM; Sureshkumar KK; Ko TY; Marcus RJ
Transplant Proc; 2013; 45(1):119-21. PubMed ID: 23283292
[TBL] [Abstract][Full Text] [Related]
12. Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States.
Riad S; Jackson S; Chinnakotla S; Verghese P
Pediatr Transplant; 2021 Aug; 25(5):e13925. PubMed ID: 33333629
[TBL] [Abstract][Full Text] [Related]
13. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
Sampaio MS; Chopra B; Sureshkumar KK
Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab induction and antibody-mediated rejection in kidney transplantation.
Noureldeen T; Albekioni Z; Machado L; Muddana N; Marcus RJ; Hussain SM; Sureshkumar KK
Transplant Proc; 2014 Dec; 46(10):3405-7. PubMed ID: 25498060
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
Aydin-Ghormoz EA; Perlmutter J; Koizumi N; Ortiz J; Faddoul G
Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Kidney Transplantation in Patients Exposed to Hepatitis B Virus: Analysis by Phase of Infection.
Chopra B; Sureshkumar KK
Transplant Proc; 2017 Mar; 49(2):278-280. PubMed ID: 28219584
[TBL] [Abstract][Full Text] [Related]
17. Outcomes Associated with Steroid Avoidance and Alemtuzumab among Kidney Transplant Recipients.
Serrano OK; Friedmann P; Ahsanuddin S; Millan C; Ben-Yaacov A; Kayler LK
Clin J Am Soc Nephrol; 2015 Nov; 10(11):2030-8. PubMed ID: 26342042
[TBL] [Abstract][Full Text] [Related]
18. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
19. Human Leukocyte Antigen Mismatch and Steroid Maintenance in Kidney Transplantation.
Chopra B; Sureshkumar KK
Transplant Proc; 2015 Dec; 47(10):2852-4. PubMed ID: 26707301
[TBL] [Abstract][Full Text] [Related]
20. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
